Global Balloon Angioplasty Catheters Market 2024-2030

    In Stock

    BALLOON ANGIOPLASTY CATHETERS MARKET

     

    INTRODUCTION

    Coronary artery disease (CAD) is the most common kind of heart disease, affecting over Americans.

     

    The most common cause of CAD is atherosclerosis, which occurs when a waxy material accumulates inside the arteries that carry blood to heart. As the plaque accumulates, the artery narrows, making blood flow to the heart more difficult.

     

    As the blockage worsens, blood flow to the heart decreases, and a condition known as angina develops. A constricted or clogged artery might eventually lead to a heart attack.

     

    A variety of medications can be used to treat the angina discomfort associated with CAD. However, because drugs cannot remove clogged arteries, a severely constricted coronary artery may require surgery.

     

    Angioplasties, which open narrowed arteries, are performed by interventional cardiologists. They utilize a catheter, which is a long, thin tube with a little balloon on the tip.

     

    They inflate the balloon at the site of the arterial blockage in order to flatten or compress the plague against the artery wall. Percutaneous transluminal coronary angioplasty (PTCA) is another name for angioplasty.

     

    Although this item focuses on the coronary arteries in the heart, balloon angioplasty may be used to widen restricted veins in many other places of the body.

     

    Carotid angioplasty, for example, can be used to widen constricted carotid arteries, which are the arteries that feed blood to the brain.

     

    A stroke most commonly develops when the carotid arteries get clogged, preventing adequate oxygen from reaching the brain. 

     

    Angioplasties, which open narrowed arteries, are performed by interventional cardiologists. They utilize a catheter, which is a long, thin tube with a little balloon on the tip.

     

    They inflate the balloon at the site of the arterial blockage in order to flatten or compress the plague against the artery wall. Percutaneous transluminal coronary angioplasty (PTCA) is another name for angioplasty.

     

    Although this item focuses on the coronary arteries in the heart, balloon angioplasty may be used to widen restricted veins in many other places of the body.

     

    Carotid angioplasty, for example, can be used to widen constricted carotid arteries, which are the arteries that feed blood to the brain. A stroke is most commonly caused when the carotid arteries get clogged and the brain does not receive enough oxygen.

     

    A stent is a tiny, metal mesh-like device. When a stent is inserted into a coronary artery, it works as a scaffold or support, keeping the conduit open.

     

    The stent improves blood flow to the heart muscle and reduces angina symptoms by keeping the channel open. Stent treatments are frequently performed in conjunction with balloon angioplasty. In fact, around 80% of patients who have balloon angioplasty will also have a stent put.

     

    Stents, like balloon angioplasty, are now used in many other regions of the body than the heart. Stents can also be implanted in the neck’s carotid arteries, the aorta, and the legs peripheral arteries. Angioplasty can also be used for

     

    Doctors are always looking for novel techniques to keep arteries from shutting again following an angioplasty or stent surgery.

     

    Doctors have employed new types of stents in recent years. Some of them are coated with medications that prevent the artery from shutting again.

     

    These coated stents gradually release their medication into the surrounding tissue, delaying or preventing restenosis. Coated stents have shown promise in terms of increasing the procedure’s long-term success.

     

    Tiny stents and custom-designed stents are also being developed by researchers to fit into tiny arteries.

     

    They are also developing stents for veins with multiple blockages, such as those with side branches. To prevent blood clots from developing within the stent, other stents are being coated with blood-thinning medications. 

     

    Researchers have lately begun designing non-metal stents that will dissolve into the artery over time. These stents open the artery similarly to metal stents, but they lessen the danger of restenosis since they do not remain in the artery.

     

    BALLOON ANGIOPLASTY CATHETERS MARKET SIZE AND FORECAST

     

    infographic: Balloon Angioplasty Catheters Market, Balloon Angioplasty Catheters Market Size, Balloon Angioplasty Catheters Market Trends, Balloon Angioplasty Catheters Market Forecast, Balloon Angioplasty Catheters Market Risks, Balloon Angioplasty Catheters Market Report, Balloon Angioplasty Catheters Market Share

     

    The Global Balloon Angioplasty Catheters Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

     

    BALLOON ANGIOPLASTY CATHETERS MARKET NEW PRODUCT LAUNCH

    Medtronic plc, a worldwide leader in medical technology, today announced the availability of the Prevail drug-coated balloon (DCB) catheter in Europe following CE (Conformité Européene) certification.

     

    The Prevail DCB, the most recent coronary DCB on the market, is used during percutaneous coronary intervention (PCI) operations to treat restricted or blocked coronary arteries in patients with coronary artery disease (CAD).

     

    The balloon is inflated within the artery during the catheter-based operation, and the medication is administered to the arterial tissue, where it is absorbed.

     

    The Prevail DCB employs paclitaxel, a medication with quick absorption, to treat de novo lesions, small vascular disease, and in-stent restenosis (ISR).

     

    DCB angioplasty does not need a permanent implant and is frequently used in situations when the placement of a permanent implant is not possible.

     

    As physicians treat more patients with complicated lesions, it is vital to have a drug-coated balloon that is highly deliverable across a wide range of vasculatures and uses a medication that absorbs fast into the artery.

     

    The Prevail DCB is a fantastic alternative for interventional cardiologists who use DCB technology to treat their patients due to its high deliverability and a strong safety profile supported by clinical evidence.

     

    The PREVAIL DCB expands on the previous generation IN.PACT Falcon DCB clinical program’s exceptional safety and efficacy, which was reinforced by the PREVAIL Study presented at the PCR e-Course conference.

     

    The Prevail DCB performed exceptionally well in the PREVAIL Study in patients with complicated lesions, including those with tiny arteries and those treated with chemotherapy.

     

    BALLOON ANGIOPLASTY CATHETERS MARKET COMPANY PROFILE

     

    BALLOON ANGIOPLASTY CATHETERS MARKET THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

    • How many  Balloon Angioplasty Catheters   are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    • Cost breakup of a Global Balloon Angioplasty Catheters   and key vendor selection criteria
    • Where are the Balloon Angioplasty Catheters  manufactured? What is the average margin per unit?
    • Market share of Global Balloon Angioplasty Catheters   market  manufacturers and their upcoming products
    • Cost advantage for OEMs who manufacture Global Balloon Angioplasty Catheters   in-house
    • 5 key predictions for next 5 years in Global Balloon Angioplasty Catheters   market
    • Average B-2-B  Balloon Angioplasty Catheters market price in all segments
    • Latest trends in  Balloon Angioplasty Catheters market, by every market segment
    • The market size (both volume and value) of the  Balloon Angioplasty Catheters   market in 2024-2030 and every year in between?
    • Production breakup of  Balloon Angioplasty Catheters   market, by suppliers and their OEM relationship

     

     

     

    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
     
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop